Imagine a future where every PETCT scan delivers faster, sharper images and fewer diagnostic doubts or discrepancies – that is the potential transformative power of AI. I won’t take you through what AI, or machine learning (ML), is; for that can I simply direct you to another RAD Magazine article entitled ‘AI in multimodality imaging’ […]
Dr Peter Strouhal
Alliance Medical
Prostate cancer is the second most common cancer in the world, predicted to rise by 15% by 2025, while detection in late stage disease increased from 3.9% to 8.2% over the past decade in the USA. Primary investigations for clinical diagnosis and staging of prostate cancer include blood tests, biopsy and imaging techniques such as […]
Rayjanah Allie, Dr Dimitris Priftakis, Professor Jamshed Bomanji
University College London Hospitals NHS Foundation Trust
Breast cancer staging is a complex process, mainly due to the heterogeneous phenotype of the tumour. In early breast cancer, assessed by primary tumour size and nodal status, contrast-enhanced CT thorax, abdomen and pelvis (CECT) for staging is not indicated unless there are clinical symptoms of metastatic disease because the risk of distant spread in […]
Dr Lyn Zimmo, Dr Stefan Voo, Professor Sabina Dizdarevic
University Hospitals Sussex; University College London
Hybrid imaging is an integral part of nuclear medicine services. The possibility to combine morphologic and functional data has changed patient pathways and had a major impact in the diagnosis and management of oncology patients. CT using contrast enhancement (ceCT) is an important tool to monitor anatomical change. However, with lymphoma imaging, delineation of pathologic […]
Ana Matos
West of Scotland PET Centre
Pancreatic cancer is considered the 10th most common malignancy globally with a poor prognosis (fourth most common cause of overall cancer deaths). The most common age at diagnosis is 65-74 years. The five-year survival rate is approximately 11.5% as per the latest SEER 17 data (ranging from 44% for localised disease to 3% for distant […]
Dr Sai Sradha Patro, Dr Kanhaiyalal Agrawal, Dr Gopinath Gnanasegaran
AIIMS India, Royal Free London NHS Foundation Trust
Despite significant advances in medicine, cardiovascular diseases continue to be one of the leading causes of morbidity and mortality. Early detection and appropriate management can significantly reduce the burden on healthcare providers. PET with x-ray CT (PETCT) has inherent advantages over conventional SPECT cardiac imaging but its routine use in cardiology is limited by high […]
Dr Banu SathyaMurthi, Dr Parthiban Arumugam
Manchester University NHS Foundation Trust
CT-based attenuation correction (AC) is a fundamental component of clinical PETCT imaging and its accuracy is dependent on the integrity of the CT data. The method for AC is a multi-step process, starting with conversion of CT data to the equivalent mass-attenuation coefficient for 511keV photons (μ511keV), reduction of the data volume to that of […]
Matthew Memmott
Manchester University NHS Foundation Trust
Oesophageal cancer is the third most common gastrointestinal (GI) malignancy worldwide, with a reported incidence of 9,101 new cases per annum in the UK. Its incidence is higher with increasing age and maximum in the elderly population. It is an aggressive cancer with a late presentation. It has a poor prognosis with a five-year survival […]
Dr Hajira Ilyas, Dr Teresa Szyszko, Dr Sugama Chicklore
King's College London and Guy's and St Thomas' PET Centre